Kane MP - Search Results

1

Efficacy of teriparatide in patients with resolved secondary hyperparathyroidism due to vitamin D deficiency.

Traina AN, Kane MP, Bakst G, Busch RS, Abelseth JM, Hamilton RA. Traina AN, et al. Among authors: kane mp. Endocr Pract. 2011 Jul-Aug;17(4):568-73. doi: 10.4158/EP10228.OR. Endocr Pract. 2011. PMID: 21454243

2

Substitution of pioglitazone for troglitazone in patients with type 2 diabetes.

Kane MP, Busch RS, Bakst G, Hamilton RA. Kane MP, et al. Endocr Pract. 2004 Jan-Feb;10(1):18-23. doi: 10.4158/EP.10.1.18. Endocr Pract. 2004. PMID: 15251617

3

Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.

Rivers SM, Kane MP, Busch RS, Bakst G, Hamilton RA. Rivers SM, et al. Among authors: kane mp. Endocr Pract. 2007 Jan-Feb;13(1):11-6. doi: 10.4158/EP.13.1.11. Endocr Pract. 2007. PMID: 17360295

4

Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitus.

Sheffield CA, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Sheffield CA, et al. Among authors: kane mp. Endocr Pract. 2008 Apr;14(3):285-92. doi: 10.4158/EP.14.3.285. Endocr Pract. 2008. PMID: 18463034

5

Pharmacist-run teriparatide clinic.

Stroup J, Kane MP, Busch RS. Stroup J, et al. Among authors: kane mp. Am J Health Syst Pharm. 2003 Nov 1;60(21):2247-9. doi: 10.1093/ajhp/60.21.2247. Am J Health Syst Pharm. 2003. PMID: 14619118 No abstract available.

6

Drug-induced thyrotoxic periodic paralysis.

Kane MP, Busch RS. Kane MP, et al. Ann Pharmacother. 2006 Apr;40(4):778-81. doi: 10.1345/aph.1G543. Epub 2006 Mar 14. Ann Pharmacother. 2006. PMID: 16537816

7

Primer on pramlintide, an amylin analog.

Traina AN, Kane MP. Traina AN, et al. Among authors: kane mp. Diabetes Educ. 2011 May-Jun;37(3):426-31. doi: 10.1177/0145721711403011. Epub 2011 Apr 6. Diabetes Educ. 2011. PMID: 21471470

8

Spontaneous resolution of primary hyperparathyroidism in parathyroid adenoma.

Micale SJ, Kane MP, Busch RS. Micale SJ, et al. Among authors: kane mp. Case Rep Endocrinol. 2012;2012:793753. doi: 10.1155/2012/793753. Epub 2012 Oct 30. Case Rep Endocrinol. 2012. PMID: 23198183 Free PMC article.

9

SGLT-2 INHIBITOR THERAPY ADDED TO GLP-1 AGONIST THERAPY IN THE MANAGEMENT OF T2DM.

Saroka RM, Kane MP, Busch RS, Watsky J, Hamilton RA. Saroka RM, et al. Among authors: kane mp. Endocr Pract. 2015 Dec;21(12):1315-22. doi: 10.4158/EP15877.OR. Epub 2015 Aug 26. Endocr Pract. 2015. PMID: 26307900

10

Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes.

Busch RS, Kane MP. Busch RS, et al. Among authors: kane mp. Postgrad Med. 2017 Sep;129(7):686-697. doi: 10.1080/00325481.2017.1342509. Epub 2017 Jun 28. Postgrad Med. 2017. PMID: 28657399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters